Isodiol International Inc (ISOLF)
Isodiol International Inc. is a healthcare company focused on hemp-based consumer products and related solutions in Canada and the United States. The company develops and manufactures phytoceutical products using pharmaceutical- and nutraceutical-grade phytochemical compounds, including cannabinoid crystalline isolates derived from exempt parts of the hemp plant. Its activities also include micro-encapsulation and nanotechnology applications for ingestible and topical skin care products. In addition, Isodiol is involved in the production and distribution of hemp oil, nicotine e-liquids, personal care products, hemp-infused beverages, apparel and merchandising solutions, and certain pharmaceutical products. The company is headquartered in Vancouver, Canada, and its common stock trades on OTC Markets.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ISOL.F
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.128 K
|
—
|
—
|
—
|
—
|
—
|
—
|
